Cargando…
APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice
BACKGROUND: Alzheimer’s disease (AD) causes progressive loss of memory and cognition, exacerbated by APOE4, the greatest genetic risk factor for AD. One proposed mechanism for apolipoprotein E (apoE) effects on cognition is via NMDAR-dependent signaling. APOE genotype-specific effects on this pathwa...
Autores principales: | Liu, De-shan, Pan, Xiao-dong, Zhang, Jing, Shen, Hui, Collins, Nicole C, Cole, Arron M, Koster, Kevin P, Ben Aissa, Manel, Dai, Xiao-man, Zhou, Meng, Tai, Leon M, Zhu, Yuan-gui, LaDu, Mary Jo, Chen, Xiao-chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391134/ https://www.ncbi.nlm.nih.gov/pubmed/25871877 http://dx.doi.org/10.1186/s13024-015-0002-2 |
Ejemplares similares
-
APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
por: Balu, Deebika, et al.
Publicado: (2023) -
Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice
por: Maldonado Weng, Juan, et al.
Publicado: (2019) -
HYPERTENSION DOES NOT CONTRIBUTE TO MICROBLEEDS ONSET IN FEMALE EFAD MICE
por: Cacciottolo, Mafalda, et al.
Publicado: (2019) -
APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective
por: Tai, Leon M., et al.
Publicado: (2015) -
EASO and EFAD Position Statement on Medical Nutrition Therapy for the Management of Overweight and Obesity in Children and Adolescents
por: Hassapidou, Maria, et al.
Publicado: (2022)